A roundup of all the latest news on www.globaluniversityventuring.com for our subscribers.
Big deal: Nightstar shines bright in $800m acquisition
Nightstar Therapeutics, based on Oxford research, stands to receive $800m from Biogen in an acquisition deal that comes a year and a half after completing a $75m IPO.
Imperial internalises tech transfer
ICL will restore internal tech transfer activities from its Imperial White City Incubator, in the process ending its arrangement with commercialisation firm IP Group.
Larter lands at Calgary
Stephen Larter has become Calgary’s associate vice-president for research and innovation, adding to his duties as chief scientist of the university’s CDL-Rockies accelerator for energy startups.
Sarepta rakes in Myonexus for $165m
Sarepta Therapeutics exercised its option to acquire Nationwide Children’s gene therapy spinout Myonexus Therapeutics after paying at least $60m for the right in May 2018.
New Orleans institutions prepare life sciences accelerator
Tulane University and LSU…
